AIDS primary central nervous system lymphoma

Current Opinion in Oncology

Volumn 8, Issue 5, 1996, Pages 373-376

  Flinn, Ian W ^a   Ambinder, Richard F ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIGEN EXPRESSION; B LYMPHOCYTE; BRAIN BIOPSY; CANCER INCIDENCE; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM TUMOR; CEREBROSPINAL FLUID; EPSTEIN BARR VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOMA; MULTIMODALITY CANCER THERAPY; POLYMERASE CHAIN REACTION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; VIRUS GENE;

EID: 0029861918     PISSN: 10408746     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001622-199609000-00007     Document Type: Review

References (32)

1. Eby NL, Grufferman S, Flannelly CM, Schold SC Jr, Vogel FS, Burger PC: Increasing incidence of primary brain lymphoma in the US. Cancer 1988, 62:2461-2465.
2. Lutz JM, Coleman MP: Trends in primary cerebral lymphoma. Br J Cancer 1994, 70:716-718.
3. Cote TR, Manns A, Hardy CR, et al.: Epidemiology of brain lymphoma among people with or without acquired immunodeficiency syndrome. J Natl Cancer Inst 1996, 88:675-679. This paper characterizes the incidence of brain lymphomas in patients with and without AIDS.
4. MacMahon EME, Glass JD, Hayward SD, et al.: Epstein-Barr virus in AIDS-related primary central nervous system lymphoma. Lancet 1991, 338:969-973.
5. Beral V, Peterman T, Berkelman R, Jaffe H: AIDS-associated non-Hodgkin's lymphoma. Lancet 1991, 337:805-809.
6. Penn I: Cancer is a complication of severe immunosuppression. Surg Gynecol Obstet 1986, 162:603-610.
7. Swinnen LJ: Transplant immunosuppression-related malignant lymphomas. Cancer Treat Res 1993, 66:95-110.
8. Chang KL, Flaris N, Mickey WF, Johnson RM, Meyer JS, Weiss LM: Brain lymphomas of immunocompetent and immunocompromised patients: study of the association with Epstein-Barr virus. Mod Pathol 1993, 6:427-431.
9. Morgello S: Epstein-Barr and human immunodeficiency viruses in acquired immunodeficiency syndrome-related primary central nervous system lymphoma. Am J Pathol 1992, 141:441-450.
10. Guterman KSA, Hair LS, Morgello S: CNS lymphoma and AIDS: Epstein Barr virus and AIDS-related primary central nervous system lymphoma. Viral detection by immunohistochemistry, RNA in situ hybridization and polymerase chain reaction. Clin Neuropathol 1996, 15:79-86.
11. Camilleri-Broet S, Davi F, Feuillard J, et al.: High expression of latent membrane protein 1 of Epstein-Barr virus BCL-2 oncoprotein in acquired immunodeficiency syndrome-related primary brain lymphomas. Blood 1995, 86:432-435.
12. Murray PG, Swinnen LJ, Constandinou CM, et al.: bcl-2 But not the EBV-encoded bcl-2 homologue, BHRF-1, is commonly expressed in post transplantation lymphoproliferative disorders. Blood 1996, 87:706-711.
13. Auperin I, Mikolt J, Oksenhendler E, et al.: Primary central nervous system malignant non-Hodgkin's lymphomas from HIV-infected and non-infected patients: expression of cellular surface proteins and Epstein-Barr viral markers. Neuropathol Appl Neurobiol 1994, 20:243-252.
14. Carmichael A, Jin X, Sissons P, Borysiewicz L: Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease. J Exp Med 1993, 177:249-256.
15. Mathews C, Barba D, Fullerton SC, et al.: Early biopsy versus empiric treatment with delayed biopsy of non-responders in suspected HIV-associated cerebral toxoplasmosis: a decision analysis. AIDS 1995, 9:1243-1250.
16. Donahue BR, Sullivan JW, Cooper JS, et al.: Additional experience with empiric radiotherapy for presumed human immunodeficiency virus-associated primary central nervous system lymphoma. Cancer 1995, 76:328-332.
17. Corn BW, Trock BJ, Curran WJ: Management of primary central nervous system lymphoma for the patient with acquired immunodeficiency syndrome: confronting a clinical catch-22. Cancer 1995, 76:163-166. A very thoughtful discussion of management, with a particular focus on the benefits of biopsy.
18. Rhodes CH, Glantz MJ, Glantz L, et al.: A comparison of polymerase chain reaction examination of cerebrospinal fluid and conventional cytology in the diagnosis of lymphomatous meningitis. Cancer 1996, 77:543-548.
19. MacMahon E, Glass JD, Hayward SD, et al.: Epstein-Barr virus (EBV): a tumor marker for primary central nervous system lymphoma (PCNSL) in AIDS? Blood 1991, 78S:399a.
20. Cinque P, Brytting M, Vago L, et al.: Epstein-Barr virus DNA in cerebrospinal fluid from patients with AIDS-related primary lymphoma of the central nervous system. Lancet 1993, 342:398-401.
21. Deluca A, Antinori A, Cingolani A, et al.: Evaluation of cerebrospinal fluid EBV-DNA and IL-10 as markers for in vivo diagnosis of AIDS-related primary central nervous system lymphoma. Br J Haematol 1995, 90:844-849. New data supporting the diagnostic utility of PCR for EBV in diagnosis.
22. Arribas JR, Clifford DB, Fichtenbaum CJ, Roberts RL, Powderly WG, Storch GA: Detection of Epstein-Barr virus DNA in cerebrospinal fluid for diagnosis of AIDS-related central nervous system lymphoma. J Clin Microbiol 1995, 33:1580-1583. Further support for the diagnostic utility of PCR for EBV in diagnosis.
23. Rosenfeld SS, Hoffman JM, Coleman RE, Glantz MJ, Hanson MW, Schold SC: Studies of primary central nervous system lymphoma with fluorine-18-fluorodeoxyglucose positron emission tomography. J Nucl Med 1992, 33:532-536.
24. Hoffman JM, Waskin HA, Schifter T, et al.: FDG-PET in differentiating lymphoma from nonmalignant central nervous system lesions in patients with AIDS. J Nucl Med 1993, 34:567-575.
25. 18F-fluoro-2-deoxyglucose-positron emission tomography scanning.
26. 201TI single photon emission imaging in diagnosis. A small series but the only one in the literature.
27. Freilich RJ, Delattre JY, Monjour A, Deangelis LM: Chemotherapy without radiation therapy as initial treatment for primary CNS lymphoma in older patients. Neurology 1996, 46:435-439.
28. Dahlborg SA, Henner WD, Grossen JR, et al.: Non-AIDS primary CNS lymphoma: first example of a durable response in a primary brain tumor using enhanced chemotherapy delivery without cognitive loss and without radiotherapy. Cancer J Sci Am 1996, 2:166-174.
29. Schultz C, Scott C, Sherman W, et al.: Preirradiation chemotherapy with cyclophosphamide, doxorubicin, vincristine, and dexamethasone for primary CNS lymphomas: initial report of Radiation Therapy Oncology Group Protocol 88-06. J Clin Oncol 1996, 14:556-564.
30. Goldstein JD, Zeifer B, Chao C, et al.: CT appearance of primary CNS lymphoma in patients with acquired immunodeficiency syndrome. J Comput Assist Tomogr 1991, 15:39-44.
31. Formenti SC, Gill PS, Lean E, et al.: Primary central nervous system lymphoma in AIDS: results of radiation therapy. Cancer 1989, 63:1101-1107.
32. Forsyth PA, Yahalom J, Deangelis LM: Combined-modality therapy in the treatment of primary central nervous system lymphoma in AIDS. Neurology 1994, 44:1473-1479. An interesting discussion of combined modality therapy.